FECAL MATTER FOR PREVENTING OR TREATING INTESTINAL MICROBIOME ABERRATIONS IN CESAREAN SECTION-BORN INFANTS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20230364164A1
SERIAL NO

18246495

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A composition for use in the prevention or treatment of intestinal microbiota aberration in a Cesarean section- (CS-) born infant, wherein the use is particularly for one or more of reducing intestinal colonization of pathogenic microorganisms, increasing intestinal relative abundance of Bacteroides species and/or Bifidobacterium species, increasing intestinal microbial diversity, increasing level of intestinal secretory IgA and/or intestinal antimicrobial peptides, reducing susceptibility to a disorder particularly chosen from the group consisting of metabolic disease, obesity, type 2 diabetes, auto-immune disease, atopy-related disease, allergy and asthma, and increasing immune response to vaccines.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CAELUS PHARMACEUTICALS B V3474 KG ZEGVELD

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
De, Vos Willem Meindert Amsterdam, NL 38 193
Sterkman, Lucas Gerardus Willibror Heiloo, NL 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation